ARX:ASX
Aroa Biosurgery Ltd
A$0.52
arrow_upward
+0.96%(+0.0050) 1D
Oct 28, 3:59:09 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
A$0.52
High
A$0.52
Low
A$0.52
Mkt. cap
179.89M
Avg. vol.
247.98K
Volume
57.33K
P/E ratio
50.34
52-wk high
A$0.80
52-wk low
A$0.48
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
Open
A$0.52
High
A$0.52
Low
A$0.52
Mkt. cap
179.89M
Avg. vol.
247.98K
Volume
57.33K
P/E ratio
50.34
52-wk high
A$0.80
52-wk low
A$0.48
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
News stories
From web sources and news partners
Business Insider
·
24 minutes ago
Morgan Stanley warns the S&P 500 could drop 8% before kicking off a fresh rally
www.tmgm.com
·
47 minutes ago
Dow Jones futures decline ahead of Fed decision, big tech earnings
WSJ
·
45 minutes ago
Dow Futures Slip While Nasdaq-100 Looks Set to Rise
Business Chief
·
15 hours ago
The S&P 493: Where the AI Boom’s Money Never Arrived
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd